Cargando…
Aryl Hydrocarbon Receptor Downregulates MYCN Expression and Promotes Cell Differentiation of Neuroblastoma
Neuroblastoma (NB) is the most common malignant disease of infancy. MYCN amplification is a prognostic factor for NB and is a sign of highly malignant disease and poor patient prognosis. In this study, we aimed to investigate novel MYCN-related genes and assess how they affect NB cell behavior. The...
Autores principales: | Wu, Pei-Yi, Liao, Yung-Feng, Juan, Hsueh-Fen, Huang, Hsuan-Cheng, Wang, Bo-Jeng, Lu, Yen-Lin, Yu, I-Shing, Shih, Yu-Yin, Jeng, Yung-Ming, Hsu, Wen-Ming, Lee, Hsinyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931655/ https://www.ncbi.nlm.nih.gov/pubmed/24586395 http://dx.doi.org/10.1371/journal.pone.0088795 |
Ejemplares similares
-
Correction: Aryl Hydrocarbon Receptor Downregulates MYCN Expression and Promotes Cell Differentiation of Neuroblastoma
Publicado: (2014) -
Nuclear GRP75 Binds Retinoic Acid Receptors to Promote Neuronal Differentiation of Neuroblastoma
por: Shih, Yu-Yin, et al.
Publicado: (2011) -
Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data
por: Hsu, Chia-Lang, et al.
Publicado: (2016) -
Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation
por: Chaudhry, Kanita A., et al.
Publicado: (2023) -
VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma
por: Weng, Wen-Chin, et al.
Publicado: (2017)